Ipragliflozin

Chemical formula: C₂₁H₂₁FO₅S  Molecular mass: 404.109 g/mol  PubChem compound: 10453870

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A10BK05 A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Discover more medicines within A10BK05

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 761423-87-4
DrugBank Drug: DB11698
KEGG Drug: D10196
PubChem Compound: 10453870
UNII Identifier: 3N2N8OOR7X
IPRAGLIFLOZIN

Medicines

Ipragliflozin is an active ingredient of these brands:

Japan (JP)

  • SUGLAT as IPRAGLIFLOZIN L-PROLINE
  • (combination) SUJANU as IPRAGLIFLOZIN L-PROLINE

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈